查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1790175

美国临床实验室服务市场规模、份额和趋势分析（按测试类型、服务供应商、应用和细分预测），2025 年至 2033 年

U.S. Clinical Laboratory Services Market Size, Share & Trends Analysis Report By Test Type, By Service Provider, By Application, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

市场规模与趋势：

预计 2024 年美国临床实验室服务市场价值将达到 94.2 亿美元，预计 2025 年至 2033 年复合年增长率为 5.07%。

这个市场主要受慢性病负担日益加重的驱动，导致医疗保健机构对常规和专科诊断检测的需求不断增长。对早期诊断和预防性筛检的日益重视，进一步加速了临床实验室服务的利用，尤其是针对糖尿病、心血管疾病和癌症等疾病。

此外，样本检测量的增加显着改善了资料管理和样本製备，从而实现了更有效率的检测工作流程和更广泛的检测可用性。这些改进有助于实验室缩短週转时间，提高诊断准确性，并满足各种医疗保健机构日益增长的需求。自动化系统数位化报告工具的整合也增强了业务能力，加快了结果获取速度，并促进了临床医生和实验室专业人员之间的更好协作。

市场也见证了新进入者日益增长的兴趣，他们希望利用该行业的巨大潜力。例如，2023年2月，荷兰生物技术公司Detact Diagnostics根据一份为期两年的租赁协议，在基恩州立学院建立了一个新实验室。同样，2021年5月，Neuberg Diagnostics在美国推出了一个专门从事次世代定序（NGS）和分子诊断的实验室——这些领域对精准医疗和早期疾病检测至关重要。这些投资反映了专科检测未来前景的不断扩大，以及技术创新在塑造未来临床实验室服务方面日益重要的角色。

此外，不断变化的法规环境和对基于价值的医疗服务的关注正在进一步影响美国临床实验室服务的发展。实验室正日益努力满足美国临床实验室改进协会 (CLIA) 和美国临床病理学会 (CAP) 等组织制定的品质标准，以保持合规性并提高可靠性。同时，付款者强调成本效益和临床效用，鼓励实验室采用更有针对性的检测策略。这种转变强化了对循证诊断的需求，这些诊断方法能够支持临床决策，并有助于改善患者预后并优化医疗保健支出。

在COVID-19疫情爆发之前，超过20万家CLIA认证实验室每年进行超过130亿次临床检测，凸显了诊断在医疗保健系统中的关键作用。根据美国慢性病主管协会的数据，截至2022年，美国近60%的人口将至少患有一种慢性病，而这些基础设施在慢性病管理中发挥着至关重要的作用。随着人口老化和预防保健的转变，临床对常规和专科检测的需求只会不断增长。

此次疫情进一步凸显了诊断技术的关键作用。截至 2023 年 3 月，美国已进行了超过 11.7 亿次 COVID-19 检测。检测能力的激增加强了公共卫生防范，并加速了对实验室基础设施的投资。新进业者，例如 2023 年 2 月在基恩州立学院建立实验室的 Detact Diagnostics 和 2021 年 5 月在美国推出了次世代定序和分子诊断实验室的 Neuberg Diagnostics，都在积极利用市场潜力。此外，ProPhase 参与企业于 2024 年 11 月宣布成立 DNA Complete, Inc.，这是一个直接面向消费者的 DNA 检测平台，反映了市场对个人化诊断日益增长的趋势。癌症发生率的上升（预计 2024 年新发病例将超过 200 万）进一步刺激了对高级检测服务（尤其是专门的肿瘤检测）的持续需求。

目录

第一章调查方法与范围

第二章执行摘要

第三章美国临床实验室服务市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 美国临床实验室服务市场的分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章：美国临床实验室服务市场（按测试类型、估计和趋势分析）

  • 2024 年和 2033 年各测试类型的市场占有率
  • 细分仪表板
  • 按测试类型分類的展望
  • 2021-2033 年市场规模、预测与趋势分析
    • 基因检测
    • 临床化学
    • 医学微生物学检测
    • 血液检查
    • 免疫学检测
    • 细胞学检查
    • 药物滥用检测
    • 其他的

第五章：美国临床实验室服务市场（按服务供应商划分）、估计和趋势分析

  • 2024 年及 2033 年服务供应商市场占有率
  • 细分仪表板
  • 服务供应商展望
  • 2021-2033 年市场规模、预测与趋势分析
    • 医院附设实验室
    • 独立实验室
    • 诊所和实验室

第六章：美国临床实验室服务市场的应用、估计与趋势分析

  • 2024 年及 2033 年各应用领域的市场占有率
  • 细分仪表板
  • 按用途展望
  • 2021-2033 年市场规模、预测与趋势分析
    • 生物分析与实验室化学服务
    • 毒理学测试服务
    • 细胞和基因治疗相关服务
    • 临床前和临床试验相关服务
    • 药物发现及开发相关服务
    • 其他的

第七章 竞争态势

  • 主要市场参与企业的近期趋势和影响分析
  • 公司/竞争对手分类
  • 供应商格局
    • 主要经销商和通路合作伙伴名单
    • Key customers
    • Key company market share analysis, 2024
    • LABORATORY CORPORATION OF AMERICA HOLDINGS（LABCORP）
    • Eurofins Scientific SE
    • QIAGEN NV
    • Quest Diagnostics Incorporated
    • OPKO HEALTH, INC.
    • Charles River Laboratories International, Inc.
    • ARUP LABORATORIES
    • Sonic Healthcare
    • Neogenomics Laboratories
    • Fresenius Medical Care
    • Siemens Medical Solutions USA, Inc.
    • SYNLAB International GmbH
    • Mayo Clinic Laboratories
    • Unilabs
Product Code: GVR-4-68040-670-3

Market Size & Trends:

The U.S. clinical laboratory services market size was estimated at USD 9.42 billion in 2024 and is projected to register a CAGR of 5.07% from 2025 to 2033. The market is primarily driven by the increasing burden of chronic diseases, which has intensified the demand for routine and specialized diagnostic testing across care settings. Rising emphasis on early diagnosis and preventive screening has further accelerated the use of clinical laboratory services, particularly for conditions such as diabetes, cardiovascular disorders, and cancer.

In addition, the growing volume of sample testing has led to notable improvements in data management and sample preparation, supporting more efficient laboratory workflows and broader test availability. These enhancements are helping laboratories reduce turnaround times, improve diagnostic accuracy, and handle rising demand across various healthcare settings. Integration of automated systems and digitized reporting tools is also strengthening operational capacity, enabling faster delivery of results and better coordination between clinicians and lab professionals.

The market is also witnessing growing interest from new entrants aiming to capitalize on the sector's strong potential. Driven by the sector's lucrative prospects, new entrants are actively investing in the U.S. For instance, in February 2023, Dutch biotech firm Detact Diagnostics established a new laboratory at Keene State College under a two-year rental agreement. Similarly, in May 2021, Neuberg Diagnostics launched a U.S. lab focused on next-generation sequencing (NGS) and molecular diagnostics-key areas for precision medicine and early disease detection. These investments reflect the expanding scope of specialized testing and the increasing role of innovation in shaping future clinical laboratory services.

Moreover, the evolving regulatory environment and focus on value-based care are further influencing the development of clinical laboratory services in the U.S. Laboratories are increasingly aligning with quality standards set by organizations such as CLIA and CAP to maintain compliance and enhance credibility. At the same time, payers' emphasis on cost-effectiveness and clinical utility encourages labs to adopt more targeted testing strategies. This shift reinforces the need for evidence-backed diagnostics that support clinical decision-making and contribute to improved patient outcomes and optimized healthcare spending.

Prior to the COVID-19 pandemic, over 13 billion clinical tests were conducted annually across more than 200,000 CLIA-certified laboratories, highlighting the essential role of diagnostics in the healthcare system. This infrastructure plays a key role in managing chronic conditions, with nearly 60% of the U.S. population living with at least one chronic disease as of 2022, according to the National Association of Chronic Disease Directors. The clinical demand for routine and specialized testing continues to rise with the country's aging population and the shift toward preventive care.

The pandemic further underscored the critical role of diagnostics, with over 1.17 billion COVID-19 tests performed in the U.S. by March 2023. This surge in testing capacity has strengthened public health preparedness and accelerated investment in lab infrastructure. New entrants are actively tapping into the market's potential, such as Detact Diagnostics, which established a laboratory at Keene State College in February 2023, and Neuberg Diagnostics, which launched a U.S. lab for next-generation sequencing and molecular diagnostics in May 2021. In addition, ProPhase Labs introduced DNA Complete, Inc. in November 2024, a direct-to-consumer DNA testing platform reflecting the market's growing orientation toward personalized diagnostics. Rising cancer incidence-projected to exceed 2 million new cases in 2024-further reinforces the ongoing demand for advanced laboratory services, particularly in oncology-focused testing.

U.S. Clinical Laboratory Services Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the U.S. clinical laboratory services market report based on test type,application, and service provider:

  • Test Type Outlook (Revenue in USD Million, 2021 - 2033)
  • Genetic Testing
  • Clinical Chemistry
    • Routine Chemistry Testing
    • Therapeutic Drug Monitoring Testing
    • Endocrinology Chemistry Testing
    • Specialized Chemistry Testing
    • Other Clinical Chemistry Testing
  • Medical Microbiology Testing
    • Infectious Disease Testing
    • Transplant Diagnostic Testing
    • Other Microbiology Testing
  • Hematology Testing
  • Immunology Testing
  • Cytology Testing
  • Drug of Abuse Testing
  • Other Esoteric Tests
  • Service Provider Outlook (Revenue in USD Million, 2021 - 2033)
  • Hospital-Based Laboratories
  • Stand-Alone Laboratories
  • Clinic-Based Laboratories
  • Application Outlook (Revenue in USD Million, 2021 - 2033)
  • Bioanalytical & Lab Chemistry Services
  • Toxicology Testing Services
  • Cell & Gene Therapy Related Services
  • Preclinical & Clinical Trial Related Services
  • Drug Discovery & Development Related Services
  • Other Clinical Laboratory Services

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Test Type
    • 1.2.2. Service Provider
    • 1.2.3. Application
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in U.S.
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Test Type outlook
    • 2.2.2. Service Provider outlook
    • 2.2.3. Application outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Clinical Laboratory Services Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Technological advancements in the field of clinical testing
      • 3.2.1.2. Growing prevalence of target diseases coupled with rising demand for early disease diagnostic tests
      • 3.2.1.3. Introduction of novel solutions
      • 3.2.1.4. Outbreak of COIVD-19 pandemic
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Presence of stringent regulatory framework
  • 3.3. U.S. Clinical laboratory services market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. U.S. Clinical laboratory services market: Test Type Estimates & Trend Analysis

  • 4.1. Test Type Market Share, 2024 & 2033
  • 4.2. Segment Dashboard
  • 4.3. U.S. Clinical laboratory services market by Test Type Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
    • 4.4.1. Genetic Testing
      • 4.4.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.4.2. Clinical Chemistry
      • 4.4.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
      • 4.4.2.2. Routine Chemistry Testing Market estimates and forecasts 2021 to 2033 (USD Million)
      • 4.4.2.3. Therapeutic Drug Monitoring Testing Market estimates and forecasts 2021 to 2033 (USD Million)
      • 4.4.2.4. Endocrinology Chemistry Testing Market estimates and forecasts 2021 to 2033 (USD Million)
      • 4.4.2.5. Specialized Chemistry Testing Market estimates and forecasts 2021 to 2033 (USD Million)
      • 4.4.2.6. Other Clinical Chemistry Testing Market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.4.3. Medical Microbiology Testing
      • 4.4.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
      • 4.4.3.2. Infectious Disease Testing Market estimates and forecasts 2021 to 2033 (USD Million)
      • 4.4.3.3. Transplant Diagnostic Testing Market estimates and forecasts 2021 to 2033 (USD Million)
      • 4.4.3.4. Other Microbiology Testing Market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.4.4. Hematology Testing
      • 4.4.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.4.5. Immunology Testing
      • 4.4.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.4.6. Cytology Testing
      • 4.4.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.4.7. Drug of Abuse Testing
      • 4.4.7.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.4.8 Other Esoteric Tests
      • 4.4.8.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. U.S. Clinical Laboratory Services Market: Service Provider Estimates & Trend Analysis

  • 5.1. Service Provider Market Share, 2024 & 2033
  • 5.2. Segment Dashboard
  • 5.3. U.S. Clinical laboratory services market by Service Provider Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
    • 5.4.1. Hospital-Based Laboratories
      • 5.4.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.4.2. Stand-Alone Laboratories
      • 5.4.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.4.3. Clinic-Based Laboratories
      • 5.4.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. U.S. Clinical Laboratory Services Market: Application Estimates & Trend Analysis

  • 6.1. Application Market Share, 2024 & 2033
  • 6.2. Segment Dashboard
  • 6.3. U.S. Clinical laboratory services market by Application Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
    • 6.4.1. Bioanalytical & Lab Chemistry Services
      • 6.4.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.4.2. Toxicology Testing Services
      • 6.4.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.4.3. Cell & Gene Therapy Related Services
      • 6.4.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.4.4. Preclinical & Clinical Trial Related Services
      • 6.4.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.4.5. Drug Discovery & Development Related Services
      • 6.4.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.4.6. Others
      • 6.4.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company market share analysis, 2024
    • 7.3.4. LABORATORY CORPORATION OF AMERICA HOLDINGS (LABCORP)
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. Eurofins Scientific SE
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. QIAGEN NV
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. Quest Diagnostics Incorporated
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. OPKO HEALTH, INC.
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. Charles River Laboratories International, Inc.
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. ARUP LABORATORIES
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Product benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. Sonic Healthcare
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Product benchmarking
      • 7.3.11.4. Strategic initiatives
    • 7.3.12. Neogenomics Laboratories
      • 7.3.12.1. Company overview
      • 7.3.12.2. Financial performance
      • 7.3.12.3. Product benchmarking
      • 7.3.12.4. Strategic initiatives
    • 7.3.13. Fresenius Medical Care
      • 7.3.13.1. Company overview
      • 7.3.13.2. Financial performance
      • 7.3.13.3. Product benchmarking
      • 7.3.13.4. Strategic initiatives
    • 7.3.14. Siemens Medical Solutions USA, Inc.
      • 7.3.14.1. Company overview
      • 7.3.14.2. Financial performance
      • 7.3.14.3. Product benchmarking
      • 7.3.14.4. Strategic initiatives
    • 7.3.15. SYNLAB International GmbH
      • 7.3.15.1. Company overview
      • 7.3.15.2. Financial performance
      • 7.3.15.3. Product benchmarking
      • 7.3.15.4. Strategic initiatives
    • 7.3.16. Mayo Clinic Laboratories
      • 7.3.16.1. Company overview
      • 7.3.16.2. Financial performance
      • 7.3.16.3. Product benchmarking
      • 7.3.16.4. Strategic initiatives
    • 7.3.17. Unilabs
      • 7.3.17.1. Company overview
      • 7.3.17.2. Financial performance
      • 7.3.17.3. Product benchmarking
      • 7.3.17.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 U.S. Clinical laboratory services market, by test type, 2021 - 2033 (USD Million)
  • Table 3 U.S. Clinical laboratory services market, by service provider, 2021 - 2033 (USD Million)
  • Table 4 U.S. Clinical laboratory services market, by application, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in U.S.
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 U.S. clinical laboratory services market: market outlook
  • Fig. 10 U.S. clinical laboratory services competitive insights
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 Penetration and growth prospect mapping
  • Fig. 14 Industry value chain analysis
  • Fig. 15 U.S. Clinical laboratory services market driver impact
  • Fig. 16 U.S. Clinical laboratory services market restraint impact
  • Fig. 17 U.S. Clinical laboratory services market strategic initiatives analysis
  • Fig. 18 U.S. Clinical laboratory services market: Test Type movement analysis
  • Fig. 19 U.S. Clinical laboratory services market: Test Type outlook and key takeaways
  • Fig. 20 Genetic Testing market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 21 Clinical chemistry market estimates and forecast 2021 - 2033 (USD Million)
  • Fig. 22 Routine chemistry testing market estimates and forecast 2021 - 2033 (USD Million)
  • Fig. 23 Therapeutic drug monitoring testing market estimates and forecast 2021 - 2033 (USD Million)
  • Fig. 24 Endocrinology chemistry testing market estimates and forecast 2021 - 2033 (USD Million)
  • Fig. 25 Specialized chemistry testing market estimates and forecast 2021 - 2033 (USD Million)
  • Fig. 26 Other clinical chemistry testing market estimates and forecast 2021 - 2033 (USD Million)
  • Fig. 27 Medical microbiology testing market estimates and forecast 2021 - 2033 (USD Million)
  • Fig. 28 Infectious disease testing market estimates and forecast 2021 - 2033 (USD Million)
  • Fig. 29 Transplant diagnostic testing market estimates and forecast 2021 - 2033 (USD Million)
  • Fig. 30 Other microbiology testing market estimates and forecast 2021 - 2033 (USD Million)
  • Fig. 31 Hematology testing market estimates and forecast 2021 - 2033 (USD Million)
  • Fig. 32 Immunology testing market estimates and forecast 2021 - 2033 (USD Million)
  • Fig. 33 Cytology testing market estimates and forecast 2021 - 2033 (USD Million)
  • Fig. 34 Drug of abuse testing market estimates and forecast 2021 - 2033 (USD Million)
  • Fig. 35 Other esoteric tests market estimates and forecast 2021 - 2033 (USD Million)
  • Fig. 36 U.S. Clinical laboratory services market: Service Provider movement Analysis
  • Fig. 37 U.S. Clinical laboratory services market: Service Provider outlook and key takeaways
  • Fig. 38 Hospital-based laboratories market estimates and forecast 2021 - 2033 (USD Million)
  • Fig. 39 Stand-alone laboratories market estimates and forecasts 2021 - 2033 (USD Million)
  • Fig. 40 Clinic-based laboratories market estimates and forecasts 2021 - 2033 (USD Million)
  • Fig. 41 U.S. Clinical laboratory services market: application movement analysis
  • Fig. 42 U.S. Clinical laboratory services market: application outlook and key takeaways
  • Fig. 43 Bioanalytical & lab chemistry services market estimates and forecast 2021 - 2033 (USD Million)
  • Fig. 44 Toxicology testing services market estimates and forecasts 2021 - 2033 (USD Million)
  • Fig. 45 Cell & gene therapy related services market estimates and forecast 2021 - 2033 (USD Million)
  • Fig. 46 Preclinical & clinical trial related services market estimates and forecasts 2021 - 2033 (USD Million)
  • Fig. 47 Drug discovery & development related services market estimates and forecast 2021 - 2033 (USD Million)
  • Fig. 48 Other U.S. Clinical laboratory services market estimates and forecasts 2021 - 2033 (USD Million)
  • Fig. 49 U.S. Clinical laboratory services market share and leading players
  • Fig. 50 U.S. market share and leading players
  • Fig. 51 U.S. SWOT
  • Fig. 52 U.S. market estimates and forecast 2021 - 2033 (USD Million)
  • Fig. 53 Market share of key market players - U.S. Clinical laboratory services market